Resolvyx Pharmaceuticals, Inc. Patent applications |
Patent application number | Title | Published |
20130316989 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE - The invention relates to methods of treating inflammatory disease comprising administering a compound of formula A, a compound of any one of formulae 1-49 or I-III, a lipoxin compound, or an oxylipin compound. | 11-28-2013 |
20120122816 | COMPOSITIONS AND METHODS FOR ORGAN PRESERVATION - The invention relates to reducing, preventing or reversing organ damage, reducing and/or preventing stem cell damage and/or death, enhancing organ preservation and/or survival, or enhancing stem cell preservation and/or survival comprising administering a compound of formula A, a compound of any one of formulae 1-49 or I-III, a lipoxin compound, an oxylipin compound, or a combination of aspirin and an omega-3 fatty acid. | 05-17-2012 |
20110190242 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE - The invention relates to methods of treating inflammatory disease comprising administering a compound of formula A, a compound of any one of formulae 1-49 or I-III, a lipoxin compound, or an oxylipin compound. | 08-04-2011 |
20090137527 | Compositions and methods for modulating immune function - The invention relates to methods of modulating immune function, suppressing immune response, treating autoimmune diseases or autoimmune disorders, and treating diseases, sequelae or pathological conditions mediated by an activation of the immune system comprising administering a compound of formula A, a compound of any one of formulae 1-49, a lipoxin compound, or an oxylipin compound. | 05-28-2009 |
20090118243 | Compositions and methods for the treatment of ophthalmic conditions - The invention relates to methods of treating ophthalmic conditions comprising administering a compound of formula A, a compound of any one of formulae 1-49, a lipoxin compound, or an oxylipin compound. | 05-07-2009 |
20080207753 | Analogues of lipid mediators derived from omega-3 PUFAs and methods of use - The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ω-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases. | 08-28-2008 |